| Serial Number | 98458857 |
| Word Mark | L LUSIS |
| Filing Date | Wednesday, March 20, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Wednesday, June 18, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 5, 2024 |
| Description of Mark | The mark consists of three circles, each missing a quarter forming the letter L, to the left of the word LUSIS. |
| Goods and Services | Injectable pharmaceuticals for treatment of anaphylactic reactions; Chemical reagents for medical purposes; Antibiotic tablets; Allergy tablets; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergies, cough, cold, flu, headache, pain; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Medicated water for the treatment of pain, nausea and muscle spasms; Medicated water-based solutions for treating skin infections and skin conditions; Medicated water for the treatment of gastrointestinal disorders; Antibiotic ointments; Anti-inflammatory ointments; Medicated ointments for treating dermatological conditions; Purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes; Biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; Diagnostic preparations for medical purposes; Chemico-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory systems; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical reagents for medical or veterinary purposes |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 20, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | LUSIS BIOSCIENCES, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | HAYWARD, CA 94545 |
| Party Name | LUSIS BIOSCIENCES, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | HAYWARD, CA 94545 |
| Party Name | Sansureus, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Ontario, CA 91761 |
| Event Date | Event Description |
| Wednesday, March 20, 2024 | NEW APPLICATION ENTERED |
| Wednesday, August 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 15, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, September 11, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, September 27, 2024 | ASSIGNED TO EXAMINER |
| Saturday, September 28, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 16, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 5, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 5, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 17, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 17, 2025 | SOU EXTENSION 1 FILED |
| Wednesday, June 18, 2025 | SOU EXTENSION 1 GRANTED |
| Wednesday, June 18, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 17, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |